Ortho-Clinical Diagnostics, Inc. FDA Inspection Record
Ortho-Clinical Diagnostics, Inc. is an FDA-registered facility (FEI 1000122536) located in ATHENS, OH, US. RegDataLab tracks 6 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Aug 3, 2021: No Action Indicated (NAI)
- Inspections on record
- 6 (2 VAI, 4 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 9, latest Feb 1, 2023
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Aug 3, 2021 | No Action Indicated (NAI) | No citations listed |
| Jan 29, 2018 | Voluntary Action Indicated (VAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Lack of or inadequate procedures (21 CFR 820.100(a)) Calibration, Inspection, etc. Procedures Lack of or Inadequ (21 CFR 820.72(a)) Report of violation of the Act (see 803.52(e)(9)) (21 CFR 806.10(a)(2)) and 1 more |
| May 21, 2013 | No Action Indicated (NAI) | No citations listed |
| Jan 17, 2013 | Voluntary Action Indicated (VAI) | Not approved or obsolete document retrieval (21 CFR 820.40(a)) |
| Mar 16, 2011 | No Action Indicated (NAI) | No citations listed |
| Sep 24, 2009 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Feb 1, 2023 | Class II | Z-1308-2023 | MicroVue C1-Inhibitor Plus EIA for measuring the amount of functional C1-lnhibitor protein… Kits with affected microtiter plates have the potential to produce low OD values, causing the run to fail, per the Validation requirements… |
| Aug 13, 2021 | Class II | Z-2477-2021 | Lyra Direct SARS-CoV-2 Assay Emergency Use Authorization-
Ref: M124.
The Lyra Direct… Revised Instructions for Use: Potential for specimens from patients with high SARS-CoV-2 viral loads to be falsely interpreted as negative… |
| Apr 27, 2021 | Class I | Z-1928-2021 | Lyra SARS-CoV-2 Assay (M120) in vitro diagnostic test reagent In rare situations patients infected with high viral load of SARS CoV 2 may have samples that generate Ct values less than or equal to (d) 5… |
| Apr 4, 2017 | Class II | Z-1496-2018 | MicroVue CIC-C1q EIA, Model A001. An enzyme immunoassay for the detection of circulating… There is a potential for the slope of the standard curve to fail to meet the assay validation requirements for the assay. |
| Oct 26, 2016 | Class III | Z-1520-2018 | Quidel MicroVue Intact PTH EIA, Model 8044. An enzyme immunoassay for the quantification… There may be a loss of separation between Calibrators A and B which may impact the assay calibration at the lower end of the assay. |
| Jul 14, 2016 | Class II | Z-1797-2018 | MicroVue BAP EIA, Model 8012, provides a quantitative measure of bone-specific alkaline… There is a possibility of low volume and/or leaking standard bottles. |
| Nov 3, 2015 | Class III | Z-1497-2018 | MicroVue CIC-C1q EIA, Model A001. The MicroVue CIC-C1q EIA is for detection of circulating… and 2 more products A component of the kit was found to contain bacterial contamination. |
| Oct 16, 2014 | Class II | Z-0417-2015 | MicroVue Bb Plus EIA is packaged as a kit which contains all reagent components to perform… Samples are quantitating incorrectly, with approximately 50% higher concentration values than previously reported and historically… |
| Dec 31, 2012 | Class III | Z-0792-2013 | Diagnostic Hybrids, Inc., RhMK, Model #:49-0600, 49-0600A, 49-0102A, and 49-T075A… RhMK product fungal contamination. |
FDA record score
10 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
8 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Class I recall Z-1928-2021, this FEI as the recalling firm | Apr 27, 2021 | 15 x 0.25 | 3.8 |
| Class II recall Z-1308-2023, this FEI as the recalling firm | Feb 1, 2023 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Jan 29, 2018 | 6 x 0.25 | 1.5 |
| Class II recall Z-2477-2021, this FEI as the recalling firm | Aug 13, 2021 | 4 x 0.25 | 1 |
| Class II recall Z-1496-2018, this FEI as the recalling firm | Apr 4, 2017 | 4 x 0.25 | 1 |
| Class II recall Z-1797-2018, this FEI as the recalling firm | Jul 14, 2016 | 10 years or older, so it adds no points | 0 |
| Class II recall Z-0417-2015, this FEI as the recalling firm | Oct 16, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jan 17, 2013 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 22, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
| Warning letter text | Nov 22, 2026 | Newest record Nov 17, 2026 | Current |
| Recalls (Enforcement Report) | Nov 22, 2026 | Newest record Nov 18, 2026 | Current |
| Form 483s and inspection documents | Nov 18, 2026 | Newest record Nov 17, 2026 | Current |
| Import refusals | Nov 22, 2026 | Newest record Nov 12, 2026 | Current |
Reviewing Ortho-Clinical Diagnostics, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Ortho-Clinical Diagnostics, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Quidel Corporation
- Location
- ATHENS, OH (US)
- Source
- device